Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD. (Q37820920)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD. |
scientific article |
Statements
1 reference
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD. (English)
1 reference
Garry M Walsh
1 reference
1 November 2010
1 reference
1 reference
11
1 reference
11
1 reference
1305-1312
1 reference
Identifiers
1 reference